Company Filing History:
Years Active: 2009-2010
Title: The Innovations of Yong Yao Xu
Introduction
Yong Yao Xu is a notable inventor based in Belmont, MA, who has made significant contributions to the field of cancer research. With a total of two patents to his name, his work focuses on the identification, assessment, prevention, and therapy of ovarian and breast cancers. His innovative approaches have the potential to impact the lives of many individuals affected by these diseases.
Latest Patents
Yong Yao Xu's latest patents include groundbreaking inventions related to cancer detection and treatment. The first patent involves nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer. This invention provides compositions, kits, and methods for detecting, characterizing, preventing, and treating human ovarian cancers. The second patent addresses similar needs for breast cancer, detailing nucleic acid molecules and proteins associated with the disease. This invention also offers compositions, kits, and methods for detecting, characterizing, preventing, and treating human breast cancers.
Career Highlights
Throughout his career, Yong Yao Xu has worked with prominent organizations, including Millennium Pharmaceuticals Limited and the University of Texas System. His experience in these institutions has allowed him to develop and refine his innovative ideas, contributing to advancements in cancer research.
Collaborations
Yong Yao Xu has collaborated with several notable individuals in his field, including John E Monahan and Sebastian Hoersch. These partnerships have likely enhanced his research and development efforts, leading to the successful patents he holds today.
Conclusion
Yong Yao Xu's contributions to cancer research through his patents demonstrate his commitment to improving healthcare outcomes. His innovative work in identifying and treating ovarian and breast cancers showcases the importance of research and development in the fight against these diseases.